These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26902877)

  • 21. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
    Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2023 Jan; 9(1):125-132. PubMed ID: 35918270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.
    Viers BR; Houston Thompson R; Boorjian SA; Lohse CM; Leibovich BC; Tollefson MK
    Urol Oncol; 2014 Nov; 32(8):1277-84. PubMed ID: 25017696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
    Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
    J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
    Trinh QD; Sukumar S; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon JD; Jeldres C; Zorn KC; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    Ann Surg Oncol; 2013 Jun; 20(6):2096-102. PubMed ID: 23263779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
    Trinh QD; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon J; Jeldres C; Zorn K; Sukumar S; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    BJU Int; 2012 Jul; 110(2 Pt 2):E21-7. PubMed ID: 22044638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
    Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
    Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first competing risk survival nomogram in patients with papillary renal cell carcinoma.
    Su X; Hou NN; Yang LJ; Li PX; Yang XJ; Hou GD; Gao XL; Ma SJ; Guo F; Zhang R; Zhang WH; Qin WJ; Wang FL
    Sci Rep; 2021 Jun; 11(1):11835. PubMed ID: 34088935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
    Blum KA; Silagy AW; Knezevic A; Weng S; Wang A; Mano R; Marcon J; DiNatale RG; Sanchez A; Tickoo S; Gupta S; Motzer R; Haas NB; Kim SE; Uzzo RG; Coleman JA; Hakimi AA; Russo P
    BJU Int; 2024 Feb; 133(2):169-178. PubMed ID: 37589200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
    Meskawi M; Becker A; Bianchi M; Trinh QD; Roghmann F; Tian Z; Graefen M; Perrotte P; Karakiewicz PI; Sun M
    Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.
    Shuch B; Bratslavsky G; Shih J; Vourganti S; Finley D; Castor B; Treat E; Linehan WM; Pantuck AJ; Said JW; Belldegrun AS
    BJU Int; 2012 Jun; 109(11):1600-6. PubMed ID: 22221668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.
    Sun M; Becker A; Tian Z; Roghmann F; Abdollah F; Larouche A; Karakiewicz PI; Trinh QD
    Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Urol Oncol; 2020 May; 38(5):506-514. PubMed ID: 32139292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.
    Xiao WJ; Zhu Y; Dai B; Zhang HL; Ye DW
    Int Braz J Urol; 2015; 41(2):288-95. PubMed ID: 26005970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages.
    Siech C; Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Goyal JA; Tian Z; Saad F; Shariat SF; Longo N; Carmignani L; de Cobelli O; Ahyai S; Briganti A; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):593-598. PubMed ID: 38369387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study.
    Hou G; Li X; Zheng Y; Liu P; Yan F; Ju D; Zhang G; Zheng W; Gao M; Hou N; Yuan J; Wang F; Yuan J
    Int J Clin Oncol; 2020 Jul; 25(7):1356-1363. PubMed ID: 32361824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
    Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
    Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.